Thr312

Site Information
AsPILPItEFsDIPR SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 18016866

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 )
Disease tissue studied:	cervical cancer ( 3 ) , cervical adenocarcinoma ( 3 ) , lymphoma ( 1 ) , Burkitt's lymphoma ( 1 )
Relevant cell line - cell type - tissue:	HeLa (cervical) ( 2 ) , HeLa S3 (cervical) ( 3 ) , RAMOS (B lymphocyte) ( 1 )

Upstream Regulation
Treatments:	nocodazole ( 3 )

References
1	Rolland D, et al. (2014) Global phosphoproteomic profiling reveals distinct signatures in B-cell non-Hodgkin lymphomas. Am J Pathol 184, 1331-42 24667141 Curated Info
2	Kettenbach AN, et al. (2011) Quantitative phosphoproteomics identifies substrates and functional modules of aurora and polo-like kinase activities in mitotic cells. Sci Signal 4, rs5 21712546 Curated Info
3	Olsen JV, et al. (2010) Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 3, ra3 20068231 Curated Info